Trial no.:
|
PACTR202306811590520 |
Date of Approval:
|
21/06/2023 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
comparison of the postoperative analgesia of different volumes of bupivacaine for Ultrasound-guided Rhomboid Intercostal Block in patient undergoing Modified Radical Mastectomy: a Randomized Controlled Trial
|
Official scientific title |
Efficacy of Two Volumes of Bupivacaine 0.375% on Postoperative Analgesia in Ultrasound-guided Rhomboid Intercostal Block in Modified Radical Mastectomy: a Randomized Controlled Trial
|
Brief summary describing the background
and objectives of the trial
|
Breast cancer is the commonest cancer in females. Modified radical mastectomy is the main procedure for the treatment of breast cancer.
Acute pain control prevents surgical response and decreases the need for opioids and analgesics to preserve immune function. Opioids especially morphine may be responsible for higher rates of infection and local recurrence, even metastasis through suppression of both cellular and humoral immunity. As well as previous studies have reported that acute postoperative pain is highly associated with the development of chronic pain.
The regional anesthetic technique proved better control of Acute pain and hence less chronic pain. There are many techniques for regional anesthesia in breast surgery. For example, thoracic epidural blockade, thoracic paravertebral blockade, and intercostal nerve blockade are associated with difficulty and higher rates of complications
The rhomboid intercostal block is a novel regional analgesia technique that controls pain after surgery involving the chest wall. it is an easy technique and has nearly no complications. This study aimed to compare the postoperative analgesia of two different volumes of bupivacaine for an ultrasound-guided rhomboid intercostal plane block in patients undergoing modified radical mastectomy.
This study was a randomized controlled double-blinded study that included 82 patients and was scheduled for modified radical mastectomy under general anesthesia (GA), patients were randomly assigned into 2 equal groups; rhomboid intercostal plane block with 25 ml of 0.375% isobaric bupivacaine in 41 patients (Group V 25) and rhomboid intercostal plane block with 40 ml of 0.375% isobaric bupivacaine in 41 patients (Group V 40).
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,Cancer,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/07/2021 |
Actual trial start date |
01/09/2021 |
Anticipated date of last follow up |
01/12/2022 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
114 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|